LIGAND PHARMACEUTICALS INCORPORATED Derivative, Gain (Loss) on Derivative, Net
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) reported Derivative, Gain (Loss) on Derivative, Net of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:DerivativeGainLossOnDerivativeNet · last filed 2026-08-07
- LIGAND PHARMACEUTICALS INCORPORATED derivative, gain (loss) on derivative, net for the quarter ending 2026-06-30 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED derivative, gain (loss) on derivative, net for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED derivative, gain (loss) on derivative, net for the quarter ending 2025-12-31 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED derivative, gain (loss) on derivative, net for the quarter ending 2025-09-30 was $833.00K.
- LIGAND PHARMACEUTICALS INCORPORATED derivative, gain (loss) on derivative, net for fiscal 2025 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED derivative, gain (loss) on derivative, net for fiscal 2024 was -$15.05M.
- LIGAND PHARMACEUTICALS INCORPORATED derivative, gain (loss) on derivative, net for fiscal 2023 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED derivative, gain (loss) on derivative, net for fiscal 2022 was $0.00.
| Period end | Derivative, Gain (Loss) on Derivative, Net 3 month | Derivative, Gain (Loss) on Derivative, Net 6 month | Derivative, Gain (Loss) on Derivative, Net 9 month | Derivative, Gain (Loss) on Derivative, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-07 | $0.00 10-Q · filed 2026-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-08-07 | $833.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-05-08 | $833.00K derived: sum of 3 quarters · filed 2026-05-08 | -$443.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $833.00K derived: sum of 2 quarters · filed 2026-02-27 | -$443.00K derived: sum of 3 quarters · filed 2026-08-07 | $0.00 10-K · filed 2026-02-27 |
| 2025-09-30 | $833.00K 10-Q · filed 2025-11-07 | -$443.00K derived: sum of 2 quarters · filed 2026-08-07 | $0.00 10-Q · filed 2025-11-07 | -$7.24M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$1.28M 10-Q · filed 2026-08-07 | -$833.00K 10-Q · filed 2026-08-07 | -$8.08M derived: sum of 3 quarters · filed 2026-08-07 | -$15.89M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $443.00K 10-Q · filed 2026-05-08 | -$6.80M derived: sum of 2 quarters · filed 2026-05-08 | -$14.61M derived: sum of 3 quarters · filed 2026-05-08 | -$14.61M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$7.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$15.05M derived: sum of 2 quarters · filed 2026-02-27 | -$15.05M derived: sum of 3 quarters · filed 2026-02-27 | -$15.05M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$7.81M 10-Q · filed 2025-11-07 | -$7.81M derived: sum of 2 quarters · filed 2025-11-07 | -$7.81M 10-Q · filed 2025-11-07 | -$7.81M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | $0.00 derived: sum of 3 quarters · filed 2026-02-27 | $0.00 derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-09 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 derived: sum of 3 quarters · filed 2026-02-27 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 10-K · filed 2026-02-27 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-08 | $0.00 10-Q · filed 2024-11-08 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-07 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-28 | |||
| 2019-03-31 | $3.90M 10-Q · filed 2019-05-09 | |||
| 2018-12-31 | -$1.80M 10-K · filed 2021-02-24 |